Expert Highlights Testing Standards in Patients With Colorectal Cancer
Scott Kopetz, MD, associate professor of GI Medical Oncology at MD Anderson Center, advises community oncologists on what testing should be done for patients with colorectal cancer.
Scott Kopetz, MD, associate professor of GI Medical Oncology at MD Anderson Center, advises community oncologists on what testing should be done for patients with colorectal cancer (CRC).
Updated guidelines suggest microsatellite testing (MSI) for every patient with CRC regardless of their stage. This will help in discovering the available novel therapies for your patient, Kopetz said. Other testing for this patient population should include KRAS, NRAS, and BRAF, which is currently considered a standard in this field.
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
